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OBJECTIVES: To determine the viruses and risk factors associated with hospital and intensive care unit (ICU)
admissions in infants with acute bronchiolitis.
INTRODUCTION: Bronchiolitis is a major cause of morbidity in infants. Widespread use of molecular-based methods
has yielded new insights about its etiology, but the impact of viral etiologies on early outcomes is still unclear.
METHODS: Seventy-seven infants with bronchiolitis who were under two years of age and visited an emergency unit
were included. Using molecular-based methods, samples were tested for 12 different respiratory viruses. Logistic
regression models were used to identify clinical and virological variables associated with the main endpoints:
hospital admission and ICU admission.
RESULTS: We identified at least one virus in 93.5% of patients, and coinfections were found in nearly 40% of
patients. RSV was the most common pathogen (63.6%), followed by rhinovirus (39%). Identification of RSV was only
associated with an increased risk of hospital admission in the univariate model. Younger age and enterovirus
infection were associated with an increased risk of hospital admission, while atopy of a first-degree relative showed
a protective effect. Prematurity was associated with an increased risk of admission to the ICU. Coinfections were not
associated with worse outcomes.
CONCLUSIONS: Molecular-based methods resulted in high rates of viral identification but did not change the
significant role of RSV in acute bronchiolitis. Younger age and enterovirus infection were risk factors for hospital
admission, while prematurity appeared to be a significant risk factor for admission to the ICU in acute viral
bronchiolitis.
KEYWORDS: Bronchiolitis; Respiratory Syncytial Virus; Infant; Hospitalization; Coinfections.
Nascimento MS, Souza AV, Ferreira AVS, Rodrigues JC, Abramovici S, Silva Filho LVF. High Rate of Viral Identification and Coinfections in Infants with
Acute Bronchiolitis. Clinics. 2010;65(11):1133-1137.
Received for publication on August 17, 2010; First review completed on August 23, 2010; Accepted for publication on August 23, 2010
E-mail: vicres@usp.br
Tel.: 55 11 3023-2673
INTRODUCTION
Acute viral bronchiolitis is one of the most frequent
causes of hospitalization in infants worldwide.1 Aside from
the significant financial burden it causes in developed
countries,2 the condition is responsible for many deaths
attributed to respiratory infections in developing nations.3
Respiratory syncytial virus (RSV) is the major etiological
agent responsible for bronchiolitis and is identified in 70%
of bronchiolitis cases during the fall and winter.1
Parainfluenza (PIV), adenovirus, and influenza are fre-
quently described as occurring year-round.4
The recent widespread use of molecular-based methods
has yielded new insights about the etiology of bronchiolitis
and has suggested a significant role for other viruses, such
as human metapneumovirus,5 rhinovirus,6 and corona-
viruses, in bronchiolitis.7 Currently, controversy exists
regarding whether the presence of these viruses increases
the severity of RSV. Either way, the impact of coinfections,
in general, is still unclear.8-10
Recent studies examining the etiology of bronchiolitis in
infants have reported high rates of viral detection.10-12
However, these studies have been limited to hospital-
admitted patients, which may lead them to over- or
underestimate the true significance of the roles that different
viral etiologies may play in determining the severity of
bronchiolitis.
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In this study, we investigated which viruses and risk
factors are associated with hospital admission and admis-
sion to the intensive care unit (ICU) in infants with acute
bronchiolitis.
PATIENTS AND METHODS
This study involved a prospective cohort of 77 infants
seeking medical attention on business days between 7:00
AM and 5:00 PM at the Emergency Unit of Hospital Israelita
Albert Einstein in Sa˜o Paulo, Brazil, between March 1, 2006,
and July 30, 2007. The Hospital Israelita Albert Einstein is a
private institution that mostly treats people of a high
socioeconomic status.
To be included in the study, patients had to be under two
years of age and have exhibited symptoms of acute
bronchiolitis for no longer than five days. Parents’ agree-
ment (informed consent) was also required. Bronchiolitis
was defined as the first episode of wheezing associated with
signs of an upper respiratory tract infection. Patients with
previous wheezing episodes or previous use of beta-
agonists were excluded. A structured questionnaire was
given to parents or caregivers to obtain information
regarding atopy in the family (i.e., asthma, allergic rhinitis,
or atopic dermatitis), day care attendance, exposure to
environmental tobacco smoke or pets, existence of siblings,
and pre-existing conditions such as prematurity, cardio-
pathy, or gastroesophageal reflux.
Vital signs, including pulse oximetry (Nellcor OxiMax N-
65, Covidien, Mansfield, MA, USA) and respiratory rate,
were obtained from all patients by an attending nurse. A
detailed clinical examination was performed by the pedia-
trician, who then filled out the Respiratory Distress
Assessing Instrument (RDAI)13 and made all treatment
decisions. The RDAI assesses wheezing and respiratory
distress on a scale from 0 to 17, with higher scores indicating
more severe illness, and has good interobserver reliability.
Nasopharyngeal aspirates were obtained by a respiratory
therapist by the instillation of 1 ml of saline in each nostril
and gentle suction with a silicone catheter. The sample was
immediately put on ice and sent to the laboratory for
analysis.
Nasopharyngeal aspirate samples were volume-adjusted
with saline to 3 ml, and six different aliquots were stored at -
70 C˚. Nucleic acid extraction was performed with a QIAmp
Viral RNA Mini Kit (Qiagen, Hamburg, Germany) accord-
ing to the manufacturer’s instructions. Reverse transcription
was performed with a High Capacity cDNA Archive Kit
(Applied Biosystems, Foster City, CA, USA) according to
the manufacturer’s instructions using 20 ml of the previously
extracted RNA.
Identification of respiratory viruses
The beta-actin gene was amplified from cDNA for all
samples14 for quality assurance of the sample collection and
RNA extraction/cDNA synthesis. Detection of adeno-
virus,15 human bocavirus,16 human coronavirus (including
HCoV-NL63 and HCoV-HKU1),17 and human metapneu-
movirus18 was performed by conventional PCR or RT-PCR
according to previously published protocols. Identification
of RSV,19 influenza A and B,20 parainfluenza 1, 2, and 3,20
rhinovirus, and enterovirus 21 was performed by real-time
RT-PCR as previously described.19-21 All assays included
positive (either wild-type virus or a plasmid carrying the
target sequence) and negative controls (no DNA or cDNA
added).
Conventional PCR and RT-PCR were performed in a
PTC-200 (MJ Research, Waltham, MA, USA) or Mastercycler
Gradient (Eppendorf, Hamburg, Germany) thermocycler;
bands were visualized via 1.5% agarose gel electrophoresis
and stained with ethidium bromide 0.5 mg/ml. Real-time
RT-PCR was performed in an ABI 7300 (Applied
Biosystems, Foster City, CA, USA).
Study endpoints
A hospital admission was counted when the patient
remained in the hospital for longer than 12 hours. Patients
were hospitalized if their oxygen saturation on room air
remained lower than 93% or if significant respiratory
distress persisted after initial treatment in the emergency
unit. Admission to the intensive care unit (ICU) was
determined by clinical criteria, such as the need for assisted
ventilation or close cardiorespiratory monitoring.
Statistics
Data were analyzed using SPSS version 15.0 (SPSS Inc.,
Chicago, IL, USA). Descriptive analysis calculation of
percentages, averages, standard deviations, medians, and
ranges for demographic variables and virological results.
Univariate and multivariate logistic regression models were
used to identify clinical and virological variables associated
with the main endpoints (hospital admission and admission
to the ICU). Only variables with p,0.25 in the univariate
analysis were included in the multivariate model. Results
from logistic models were described by odds ratios and 95%
confidence intervals.
Differences between means of continuous variables were
calculated using ANOVA for normally distributed data and
a Kruskal-Wallis test otherwise. A p-value , 0.05 was
considered significant.
Approval for the study was obtained from the ethics
committee of Hospital Israelita Albert Einstein. Fully
informed parental consent was obtained for all subjects.
RESULTS
Table 1 shows the patients’ characteristics. All patients
lived in an urban area, 65% were male, and the median age
was 6¡4 months; nearly half of the infants were younger
than six months. Almost 3/4 of the patients had at least one
close relative (mother, father, or brother) with reported
atopy. Twelve patients were preterm (less than 37 weeks of
gestation), most of whom (8 out of 12) were near-term (35 to
37 weeks) infants.
On admission, most patients had bronchiolitis of moder-
ate severity, with a median RDAI score of six, but no
significant difference in the severity score was observed
between age groups (0-6 months, 6-12 months, and
.12 months). An oxygen saturation lower than 95% was
observed in 21 patients (28.3%).
Treatment included nebulized beta-agonists in 83% and
systemic steroids in 46% of the patients; 32 patents (41.5%)
required hospital admission, and 8 were admitted to the
ICU. Only two patients required non-invasive ventilation,
and there were no deaths. The overall mean length of stay in
the hospital was 3.9 days, but a significantly increased
length of stay was observed among patients admitted to the
ICU (6.4 days, p = 0.012, Kruskal Wallis test).
High Rate of Viral Identification and Coinfections in Infants with Acute Bronchiolitis
Nascimento MS et al.
CLINICS 2010;65(11):1133-1137
1134
At least one viral agent was identified in 72 samples
(93.5%); RSV was the most frequently detected agent,
followed by rhinovirus, enterovirus, and human metapneu-
movirus (Table 2). Single agents (mostly RSV) were
identified in 38 samples, whereas coinfections were
observed in 34 cases (44%) and primarily involved
rhinovirus and enterovirus. Up to four different agents
were identified in some samples (Table 2 and Figure 1).
After adjusting the multivariate model, the main variables
associated with hospital admission were age, atopy in a
first-degree relative, and the identification of enterovirus
(Table 3). Identification of RSV showed a significant
association in the univariate analysis, but this effect was
not detected after including other variables in the model.
Age had an odds ratio of 0.838, meaning that an older age
led to a decrease in hospital admissions; atopy in the family
showed a similar protective effect. Identification of enter-
ovirus in the samples was associated with an increased
hospital admission rate (Table 3). Gender, lack of siblings,
prematurity, day care attendance, having relatives with
asthma, tobacco exposure, and the identification of any
other viruses were also investigated for possible associa-
tions with hospital admission rates. With regard to admis-
sion to the ICU, we investigated the same variables
described above and found prematurity to be a significant
risk factor, with an odds ratio of 24.512 (95% CI: [3.214 –
186.925], p = 0.002).
An assessment of the impact of coinfections on hospital
admissions for each viral agent was feasible only for RSV
due to the high number of single infections; we did not find
an association between coinfections and hospital or ICU
admissions. When considering all viral infections, we found
that coinfections did not result in an increase in hospital
admissions.
DISCUSSION
We identified a high rate of viruses and coinfections
among patients presenting to our emergency department
with bronchiolitis. RSV was the most significant single agent
involved. We identified at least one virus in 93.5% of
patients, and coinfections were found in nearly 40% of
patients. These findings indicate that molecular-based
approaches result in high rates of viral identification but
do not change the significant role of RSV in this condition.
A high rate of hospital admission was found (40%), and
younger age and the presence of enterovirus were asso-
ciated with an increased risk of admission. Conversely,
reported atopy in a close relative showed a protective effect
for this same endpoint. Prematurity was also significantly
associated with an increased risk of admission to the ICU.
This high rate of hospital admissions may be related to the
study design because all patients were seen in the
emergency department and not as outpatients.
Recently published studies regarding the etiology of
bronchiolitis have reported high detection rates of respira-
tory viruses ranging from 90% to 96%,9,10,12 but these
studies have included only hospitalized patients.
Previous studies performed using different combinations
of techniques have reported lower frequencies of coinfec-
tion.8 The high frequency of coinfections found in our study
is probably related to the higher sensitivity of the molecular
approach adopted in this study. This hypothesis is
supported by Miron et al.,10 who used the same method
for rhinovirus detection21 and reported a coinfection rate of
nearly 30%.10 Another advantage of the RT-PCR approach
employed in this study is its ability to identify the recently
described genotype of human rhinovirus, namely rhino-
virus C, which has been associated with a greater clinical
impact.22,23
RSV was the most common virus found in single-virus
infections, whereas rhinovirus, the second most frequently
identified virus, was mainly found in coinfections; these
Table 2 - Respiratory viruses identified in nasopharyngeal
aspirates of infants with bronchiolitis (n = 77).
Virology result
Single
infection Coinfection Total %
Respiratory syncytial
virus
26 23 49 63.6%
Rhinovirus 5 21 26 33.8%
Enterovirus 1 15 16 20.8%
Human
Metapneumovirus
4 8 12 15.6%
Human Bocavirus 1 8 9 11.7%
Parainfluenza 3 0 6 6 7.8%
Influenza A 1 1 2 2.6%
Human Coronavirus 0 2 2 2.6%
Parainfluenza 1 0 1 1 1.3%
Adenovirus 0 0 0 0.0%
Negative samples - - 5 6.5%
Figure 1 - Sample distribution of the number of viral agents
identified by nasopharyngeal aspirate in 77 infants with
bronchiolitis.
Table 1 - Demographic data of the 77 infants with
bronchiolitis included in the study at the Hospital Israelita
Albert Einstein in Sao Paulo, Brazil between March 2006
and July 2007.
Characteristic N %
Male sex 50 64.9%
Atopy in first-degree relative
none 20 25.97%
1 relative 36 46.75%
. 1 relative 20 25.97%
No siblings 24 31.16%
Prematurity 12 15.50%
Presence of
cardiopathy
3 3.90%
Environmental
tobacco exposure
15 19.40%
Day care attendance 13 16.88%
Atopic dermatitis 9 11.68%
Gastroesophageal
reflux
11 14.29%
Pets (dog or cat) 14 18.18%
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results are in agreement with previous findings.10,12 Due to
the large number of coinfections and the small number of
children in each viral category of our study, a comprehen-
sive analysis of the impact of each virus identified in
coinfections was not feasible. However, we observed that
the detection of RSV in either a single-virus infection or a
coinfection did not differ between hospital and ICU
admissions. Richard et al. 9 reported an increased risk of
admission to the ICU when a dual viral infection was found,
but the population in their study included many premature
infants and children with underlying chronic illnesses.
Marguet et al.12 did not find a difference in bronchiolitis
severity in patients infected with single-virus RSV infections
compared to those with RSV-rhinovirus coinfections. The
only differences identified were a reduction in the length of
stay when an associated rhinovirus infection was present
and that patients with a single-virus rhinovirus infection
had milder presentations.12
Interestingly, the identification of enterovirus, but not
RSV, showed a significant association with hospital admis-
sions in the multivariate model even though an enterovirus
single-virus infection was found in only one patient. Jacques
et al.24 reported a high rate of hospitalization among infants
infected with enterovirus with a clinical diagnosis of
bronchiolitis, but this finding may be biased by an
etiological criterion in the inclusion criteria for the study.
The associations of younger age with an increased risk of
hospital admissions and of prematurity with admission to
the ICU were expected. The former partially justifies our
high rate of hospital admissions because nearly half of our
patients were younger than six months of age. Airflow
resistance critically depends on airway caliber, so very
young children are more prone to respiratory failure. This
finding, also described by others,2 was not surprising.
Prematurity is a well-known risk factor for severe
bronchiolitis in this population and is the main reason for
administering prophylaxis with monoclonal anti-RSV anti-
bodies.25 Besides the risk of apnea and the need for
cardiorespiratory monitoring of these children, it has been
shown that a significant reduction in expiratory flow is
present in prematurely born children, and this flow
limitation remains for at least the first two years of life.26
However, the prematurity risk we found (OR = 24) for ICU
admissions is most likely overestimated due to the small
number of infants admitted to the ICU during the course of
our study.
The protective risk of familial atopy for hospital admis-
sions, although also reported by others,27 may be related to
the high socioeconomic level of the population studied.
In conclusion, we identified at least one virus in 93.5% of
infants with bronchiolitis as well as a high rate of
coinfections, mainly due to rhinovirus and enterovirus.
Major risk factors for hospital admission included younger
age and enterovirus infection, whereas familial atopy had a
protective effect, and prematurity was a significant risk
factor for ICU admission. The increasing recognition of
coinfections in acute bronchiolitis may impact the design
and sample size of future studies in this field.
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